171 related articles for article (PubMed ID: 34938752)
1. Differential Changes in Akt and AMPK Phosphorylation Regulating mTOR Activity in the Placentas of Pregnancies Complicated by Fetal Growth Restriction and Gestational Diabetes Mellitus With Large-For-Gestational Age Infants.
Hung TH; Wu CP; Chen SF
Front Med (Lausanne); 2021; 8():788969. PubMed ID: 34938752
[No Abstract] [Full Text] [Related]
2. Decreased placental apoptosis and autophagy in pregnancies complicated by gestational diabetes with large-for-gestational age fetuses.
Hung TH; Huang SY; Chen SF; Wu CP; Hsieh TT
Placenta; 2020 Jan; 90():27-36. PubMed ID: 32056548
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin signaling is a mechanistic link between increased endoplasmic reticulum stress and autophagy in the placentas of pregnancies complicated by growth restriction.
Hung TH; Hsieh TT; Wu CP; Li MJ; Yeh YL; Chen SF
Placenta; 2017 Dec; 60():9-20. PubMed ID: 29208245
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of mTOR and autophagy in term normal human placentas.
Zhang QX; Na Q; Song W
Rom J Morphol Embryol; 2017; 58(2):517-526. PubMed ID: 28730238
[TBL] [Abstract][Full Text] [Related]
5. Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity.
Dumolt JH; Rosario FJ; Kramer AC; Horwitz S; Powell TL; Jansson T
Clin Sci (Lond); 2023 Apr; 137(8):663-678. PubMed ID: 37014924
[TBL] [Abstract][Full Text] [Related]
6. GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta.
Yao G; Zhang Y; Wang D; Yang R; Sang H; Han L; Zhu Y; Lu Y; Tan Y; Shang Z
PLoS One; 2017; 12(1):e0170490. PubMed ID: 28125642
[TBL] [Abstract][Full Text] [Related]
7. No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in maternal obesity and gestational diabetes mellitus.
Castillo-Castrejon M; Jansson T; Powell TL
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1037-E1049. PubMed ID: 31573844
[TBL] [Abstract][Full Text] [Related]
8. Increased placental IGF-1/mTOR activity in macrosomia born to women with gestational diabetes.
Shang M; Wen Z
Diabetes Res Clin Pract; 2018 Dec; 146():211-219. PubMed ID: 30389621
[TBL] [Abstract][Full Text] [Related]
9. Expression of Mammalian Target of Rapamycin and Downstream Targets in Normal and Gestational Diabetic Human Term Placenta.
Sati L; Soygur B; Celik-Ozenci C
Reprod Sci; 2016 Mar; 23(3):324-32. PubMed ID: 26335179
[TBL] [Abstract][Full Text] [Related]
10. Fetal growth restriction exhibits various mTOR signaling in different regions of mouse placentas with altered lipid metabolism.
Dong J; Xu Q; Qian C; Wang L; DiSciullo A; Lei J; Lei H; Yan S; Wang J; Jin N; Xiong Y; Zhang J; Burd I; Wang X
Cell Biol Toxicol; 2024 Mar; 40(1):15. PubMed ID: 38451382
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide metabolism in the human placenta during aberrant maternal inflammation.
Mukosera GT; Clark TC; Ngo L; Liu T; Schroeder H; Power GG; Yellon SM; Parast MM; Blood AB
J Physiol; 2020 Jun; 598(11):2223-2241. PubMed ID: 32118291
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological correlation of large-for-gestational age placenta in pregnancies with pregestational diabetes.
Rais R; Starikov R; Robert W; Has P; He M
Pathol Res Pract; 2019 Mar; 215(3):405-409. PubMed ID: 30616883
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial content, oxidative, and nitrosative stress in human full-term placentas with gestational diabetes mellitus.
Ramírez-Emiliano J; Fajardo-Araujo ME; Zúñiga-Trujillo I; Pérez-Vázquez V; Sandoval-Salazar C; Órnelas-Vázquez JK
Reprod Biol Endocrinol; 2017 Apr; 15(1):26. PubMed ID: 28376894
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in placental trophoblast cells experiencing gestational diabetes mellitus.
Fisher JJ; Vanderpeet CL; Bartho LA; McKeating DR; Cuffe JSM; Holland OJ; Perkins AV
J Physiol; 2021 Feb; 599(4):1291-1305. PubMed ID: 33135816
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of placental neuropilin-1 in fetal growth restriction.
Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
[TBL] [Abstract][Full Text] [Related]
16. Association of placental nutrient sensing pathways with birth weight.
Lazo-de-la-Vega-Monroy ML; Mata-Tapia KA; Garcia-Santillan JA; Corona-Figueroa MA; Gonzalez-Dominguez MI; Gomez-Zapata HM; Malacara JM; Daza-Benitez L; Barbosa-Sabanero G
Reproduction; 2020 Sep; 160(3):455-468. PubMed ID: 32590347
[TBL] [Abstract][Full Text] [Related]
17. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
[TBL] [Abstract][Full Text] [Related]
18. Gestational Diabetes Mellitus-Associated Hyperglycemia Impairs Glucose Transporter 3 Trafficking in Trophoblasts Through the Downregulation of AMP-Activated Protein Kinase.
Zhang L; Yu X; Wu Y; Fu H; Xu P; Zheng Y; Wen L; Yang X; Zhang F; Hu M; Wang H; Liu X; Qiao J; Peng C; Gao R; Saffery R; Fu Y; Qi H; Tong C; Kilby MD; Baker PN
Front Cell Dev Biol; 2021; 9():722024. PubMed ID: 34796169
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of mTOR related molecules in the placenta from gestational diabetes mellitus (GDM), intrauterine growth restriction (IUGR) and preeclampsia patients.
Tsai K; Tullis B; Jensen T; Graff T; Reynolds P; Arroyo J
Reprod Biol; 2021 Jun; 21(2):100503. PubMed ID: 33826986
[TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin attenuates gestational diabetes via Akt/mTOR pathway in a rat model.
Zhang Y; Liang Y; Liu H; Huang Y; Li H; Chen B
Food Nutr Res; 2020; 64():. PubMed ID: 33240030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
